Brown, Lisle/Cummings’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $567 | Hold |
90
| – | – | ﹤0.01% | 745 |
|
2025
Q1 | $577 | Hold |
90
| – | – | ﹤0.01% | 745 |
|
2024
Q4 | $724 | Hold |
90
| – | – | ﹤0.01% | 633 |
|
2024
Q3 | $1.14K | Hold |
90
| – | – | ﹤0.01% | 594 |
|
2024
Q2 | $1.14K | Hold |
90
| – | – | ﹤0.01% | 582 |
|
2024
Q1 | $430 | Hold |
90
| – | – | ﹤0.01% | 550 |
|
2023
Q4 | $432 | Hold |
90
| – | – | ﹤0.01% | 562 |
|
2023
Q3 | $652 | Hold |
90
| – | – | ﹤0.01% | 541 |
|
2023
Q2 | $669 | Hold |
90
| – | – | ﹤0.01% | 546 |
|
2023
Q1 | $624 | Hold |
90
| – | – | ﹤0.01% | 524 |
|
2022
Q4 | $925 | Hold |
90
| – | – | ﹤0.01% | 505 |
|
2022
Q3 | $1.64K | Hold |
90
| – | – | ﹤0.01% | 477 |
|
2022
Q2 | $4.63K | Hold |
90
| – | – | ﹤0.01% | 422 |
|
2022
Q1 | $6.63K | Hold |
90
| – | – | ﹤0.01% | 422 |
|
2021
Q4 | $12.9K | Buy |
+90
| New | +$12.9K | 0.01% | 365 |
|